H16.331
Sclerosing keratitis, right eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Sclerosing keratitis is a rare eye condition characterized by inflammation and thickening of the cornea, the clear front surface of the eye. When it affects the right eye, it can cause discomfort and visual disturbances. This condition involves the scarring and hardening of the corneal tissues, leading to changes in its transparency and structure. Recognizing the signs and understanding potential causes helps in managing this condition effectively.
Causes & Symptoms
Clinical Causes: Autoimmune diseases, such as rheumatoid arthritis or lupus, which can lead to immune system attacking corneal tissues. Infections caused by bacteria, viruses, or fungi that result in inflammation and scarring. Previous eye injuries or surgeries that may trigger abnormal healing responses. Chronic inflammatory eye conditions, like keratitis or uveitis. Exposure to harmful environmental factors, including ultraviolet light or chemical irritants. Genetic predispositions that result in abnormal corneal tissue response.
Key Symptoms: Persistent eye redness in the affected eye Discomfort or a gritty sensation in the eye Decreased vision or blurred eyesight Sensitivity to light (photophobia) Tearing or watery eyes Presence of a visible corneal scar or thickening Potential eye pain or sensation of pressure
Diagnostic & Treatment
Diagnosis Path: Diagnosis of sclerosing keratitis involves a comprehensive eye examination. An ophthalmologist will evaluate visual acuity and inspect the eye's structure using slit-lamp microscopy to identify corneal thickening and scarring. Additional tests such as corneal topography, optical coherence tomography (OCT), and microbial cultures may be performed to understand the extent of tissue involvement and exclude infections. Medical history and potential causes are also reviewed to determine underlying factors contributing to the condition.
Treatment Protocols: Management strategies aim to control inflammation, prevent further scarring, and preserve vision. Treatment options may include: - Topical corticosteroids or anti-inflammatory eye drops to reduce inflammation. - Immunosuppressive medications if an autoimmune process is suspected. - Antibiotics or antifungal medications if an infection is present. - Supportive measures like lubricating eye drops to alleviate discomfort. - In severe cases, surgical intervention such as corneal transplantation might be necessary to restore vision. Regular follow-up with an eye specialist is crucial to monitor disease progression and response to therapy.
Clinical Advice & FAQs
Billing Guidance
Is H16.331 a billable ICD-10 code?
Yes, H16.331 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H16.331?
Clinical documentation must specify the nature of Sclerosing keratitis, right eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference